Dunhill Financial’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$959K Sell
453
-3,211
-88% -$847K 0.19% 55
2026
Q2
$931K Buy
3,664
+105
+3% +$24.5K 0.19% 54
2026
Q1
$870K Sell
3,559
-9
-0.3% -$2.1K 0.21% 48
2025
Q4
$728K Buy
3,568
+17
+0.5% +$3.36K 0.18% 54
2025
Q3
$658K Buy
3,551
+251
+8% +$43K 0.17% 54
2025
Q2
$504K Buy
3,300
+248
+8% +$38.1K 0.15% 59
2025
Q1
$506K Sell
3,052
-198
-6% -$31K 0.23% 46
2024
Q4
$470K Buy
3,250
+108
+3% +$16.7K 0.22% 40
2024
Q3
$509K Buy
3,142
+327
+12% +$52.1K 0.26% 37
2024
Q2
$411K Buy
2,815
+1,444
+105% +$215K 0.26% 38
2024
Q1
$217K Buy
1,371
+38
+3% +$6.05K 0.16% 48
2023
Q4
$209K Buy
+1,333
New +$204K 0.19% 42
2023
Q3
– Sell
-1,510
Closed -$252K – 81
2023
Q2
$252K Buy
+1,510
New +$244K 0.17% 55

Other funds holding JNJ

Dunhill Financial's JNJ Position: Q3 2026 in Review

Dunhill Financial reduced its Johnson & Johnson (JNJ) stake by 88% in Q3 2026, selling an estimated $847K and leaving 453 shares worth $959K. The position accounts for 0.19% of the portfolio, ranked #55.

Dunhill Financial first reported a position in JNJ in Q2 2023 and has held it in 13 quarters since. 4,735 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Dunhill Financial held 453 shares of Johnson & Johnson worth $959K as of Q3 2026.
  • Dunhill Financial sold 3,211 Johnson & Johnson shares in Q3 2026, an estimated $847K.
  • Johnson & Johnson made up 0.19% of Dunhill Financial's portfolio in Q3 2026, its #55 holding.
  • Dunhill Financial first reported a position in Johnson & Johnson in Q2 2023 and has held it in 13 quarters since.
  • 4,735 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.